Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluoride toothpaste is a topical oral care preparation containing fluoride ions, typically in the form of sodium fluoride (NaF) or sodium monofluorophosphate, used primarily for the prevention of dental caries. Developed and marketed by GSK (and its consumer healthcare spin-off Haleon), these products function by delivering fluoride to the tooth surface to promote the remineralization of enamel and inhibit demineralization caused by acid-producing oral bacteria. The fluoride ions incorporate into the dental hydroxyapatite structure to form fluorapatite, which is significantly more resistant to acid dissolution. Additionally, fluoride can interfere with the glycolytic pathway of cariogenic bacteria such as *Streptococcus mutans* by inhibiting key enzymes like enolase. In clinical trials conducted by GSK, these formulations are often evaluated in *in situ* caries models to measure their efficacy in recovering surface microhardness of demineralized enamel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluoride toothpaste.